Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CEO
3251
PUT
DELISTED
CNOOC Limited
CEO
| $713K | ﹤0.01% |
5,500
+1,600
| +41% | +$185K |
|
3252
Horace Mann Educators
HMN
$2.18B
| $712K | ﹤0.01% |
18,116
-8,485
| -32% | -$313K |
|
3253
Invesco S&P 500 Equal Weight ETF
RSP
$98.8B
| $712K | ﹤0.01% |
7,451
+2,200
| +42% | +$206K |
|
|
AXON
3254
CALL
Axon Enterprise
AXON
$42B
| $711K | ﹤0.01% |
31,400
-11,800
| -27% | -$276K |
|
3255
CALL
Teekay
TK
$988M
| $711K | ﹤0.01% |
79,600
+48,000
| +152% | +$420K |
|
3256
Brookfield
BN
$108B
| $710K | ﹤0.01% |
48,196
-25,421
| -35% | -$357K |
|
3257
TTEC Holdings
TTEC
$126M
| $710K | ﹤0.01% |
17,022
-554
| -3% | -$22.4K |
|
|
FCB
3258
DELISTED
FCB Financial Holdings, Inc.
FCB
| $709K | ﹤0.01% |
14,698
+222
| +2% | +$10.1K |
|
3259
Teradata
TDC
$2.54B
| $708K | ﹤0.01% |
20,966
-21,544
| -51% | -$669K |
|
|
FOLD
3260
PUT
DELISTED
Amicus Therapeutics
FOLD
| $706K | ﹤0.01% |
+46,800
| New | +$619K |
|
3261
CALL
WisdomTree India Earnings Fund ETF
EPI
$2.05B
| $705K | ﹤0.01% |
28,000
+8,800
| +46% | +$229K |
|
3262
CALL
iShares MSCI Japan ETF
EWJ
$22.6B
| $703K | ﹤0.01% |
12,625
-14,400
| -53% | -$785K |
|
3263
CALL
MasTec
MTZ
$21B
| $701K | ﹤0.01% |
15,100
+3,000
| +25% | +$131K |
|
|
QVCGA
3264
PUT
DELISTED
QVC Group Inc Series A
QVCGA
| $700K | ﹤0.01% |
612
+295
| +93% | +$331K |
|
3265
Oxford Industries
OXM
$562M
| $697K | ﹤0.01% |
10,966
-1,850
| -14% | -$113K |
|
3266
CALL
PENN Entertainment
PENN
$2.73B
| $697K | ﹤0.01% |
29,800
-9,900
| -25% | -$212K |
|
3267
PJT Partners
PJT
$4.44B
| $697K | ﹤0.01% |
18,211
+4,533
| +33% | +$180K |
|
|
GES
3268
DELISTED
Guess Inc
GES
| $696K | ﹤0.01% |
40,857
-13,491
| -25% | -$191K |
|
3269
PUT
BGC Group
BGC
$4.93B
| $695K | ﹤0.01% |
74,640
-106,362
| -59% | -$888K |
|
|
MDR
3270
CALL
DELISTED
McDermott International
MDR
| $695K | ﹤0.01% |
31,867
-6,266
| -16% | -$126K |
|
|
UHT
3271
Universal Health Realty Income Trust
UHT
$588M
| $694K | ﹤0.01% |
9,199
-1,732
| -16% | -$134K |
|
|
BSFT
3272
CALL
DELISTED
BroadSoft, Inc.
BSFT
| $694K | ﹤0.01% |
+13,800
| New | +$630K |
|
3273
PUT
Mohawk Industries
MHK
$9.01B
| $693K | ﹤0.01% |
2,800
-400
| -13% | -$99.6K |
|
3274
Thomson Reuters
TRI
$43.4B
| $693K | ﹤0.01% |
13,004
-512,566
| -98% | -$27.4M |
|
3275
Halozyme
HALO
$9.97B
| $692K | ﹤0.01% |
39,791
-13,708
| -26% | -$186K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.